Bench to Bedside Chat Pharmacology and Dose Optimization for First-in-Human Oncology Trials @US

U.S. Food and Drug Administration | Bench to Bedside Chat Pharmacology and Dose Optimization for First-in-Human Oncology Trials @US_FDA | Uploaded 4 weeks ago | Updated 12 hours ago
This video discusses important concepts to consider for pharmacology and dose optimization in oncology first-in human trials.

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

FSMA Laboratory Accreditation for Analyses of Foods Program: Federal Register Notice Implementation

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

REACHing Communities Video Series – An Interview with Perla Nunes

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 2

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Afternoon Portion)

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective